Blood Oxygenation Sensor

• US 20070197888A1
• Filed: 02/18/2007
• Published: 08/23/2007
• Est. Priority Date: 02/21/2006
• Status: Abandoned Application

• Current Assignee: Physical Logic AG
• Original Assignee: Physical Logic AG
• Inventors: Ofek, Eran, Axelrod, Noel
• Application Number:
  US11/676,301
• Publication Number:
  US 20070197888A1
• Time in Patent Office: Days
• US Class Current: 600/339
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14542 for measuring blood gases A61B5/14551 takes precedence
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/1459 invasive, e.g. introduced into the body by a catheter A61B5/1464 takes precedence
• CPC Class Codes: G01N 21/552 Attenuated total reflection

Abstract

A planar dielectric waveguide sensor is used to determine the concentrations of oxygenated and deoxygenated hemoglobin and other blood constituents such as pH, sugar. The planar waveguide core is in direct contact with the blood such that evanescent field of the light propagating within the core is selectively attenuated at specific wavelengths of interest. The planar waveguide has a construction that promotes strong interaction of the evanescent field with blood cells that contact it. In preferred embodiments, the waveguide is constructed of a low refractive index core to propagate an evanescent wave comparable in size to a red blood cell.

Claims

1. A method of determining the concentration of oxygenated and deoxygenated hemoglobin in blood, the method comprising the steps of:

a) providing a waveguide comprising a planar support as a cladding on a first surface with a second surface parallel to the plane of the first surface, and terminating with a reflective surface orthogonal to the direction of propagation,

b) placing the second surface of the waveguide in contact with blood

c) propagating light through the waveguide toward the mirror,

d) measuring the intensity of light reflected by the mirror.

2. A method according to claim 1 wherein said waveguide has a refractive index (n) that is between about 1.38 and about 1.45 at the absorption bands of Hb and HbO₂

3. A method according to claim 1 wherein in said step of propagating light through the waveguide toward the mirror light enters the waveguide from an optical fiber.

4. A method according to claim 3 wherein in said step of measuring the intensity of the light reflected by the mirror the light propagates to the detector via an optical fiber.

5. A method according to claim 4 wherein the light propagates to and from the waveguide via the same optical fiber.

6. A method according to claim 1 wherein the evanescent light is capable of substantially penetrating into red blood cells.

7. A method according to claim 6 wherein the waveguide has a length of at least about 10 microns and less than about 1.3 cm.

8. A method according to claim 6 wherein the waveguide has a length of less than about 40 microns.

9. A device for measuring the concentration of oxygenated and deoxygenated hemoglobin by direct contact with blood which comprises:

a) waveguide comprising a planar support as a cladding on a first surface with a second surface parallel to the plane of the first surface and capable of being exposed directly to a fluid,

b) a reflective surface orthogonal to the direction of propagation of light within the waveguide,

c) means for illuminating said waveguide,

d) means for detecting the intensity of light reflected by said mirror in relationship to the intensity of light used to illuminate the waveguide.

10. A device according to claim 9 wherein the means for illuminating said waveguide is an optical fiber.

11. A device according to claim 9 wherein the waveguide has a length of at least about 10 microns and less than about 3.5 cm.

12. A device according to claim 9 wherein the light reflected by said reflective surface is transmitted to the detection means by an optical fiber.

13. A device according to claim 9 wherein the evanescent light is capable of substantially penetrating into red blood cells.

14. A device according to claim 9 wherein the waveguide has a refractive index (n) that is less than 1.45 at the absorption bands of Hb and HbO₂.

15. A device according to claim 9 wherein the waveguide has a refractive index (n) that is between about 1.375 and about 1.45 at the absorption bands of Hb and HbO₂.

16. A device according to claim 9 wherein the waveguide has a refractive index (n) that is between about 1.38 and about 1.42 at the absorption bands of Hb and HbO₂.

17. A device according to claim 15 wherein the waveguide has a refractive index (n) that is about 1.375 and the refractive index of the cladding is about 1.36 at the absorption bands of Hb and HbO₂.

18. A device according to claim 15 wherein the waveguide has a length of at least about 10 microns and less than about 40 microns.

19. A device according to claim 16 wherein the waveguide has a length of at least about 10 microns and less than about 40 microns.

20. A device according to claim 9 wherein the planar waveguide is fabricated by the deposition of a film of HOSP material as the core on a silicon substrate.

21. A device according to claim 10 wherein the light not coupled from the optical fiber into the planar waveguide is not returned to the detection means.

22. A device according to claim 10 wherein the light not coupled from the optical fiber into the planar waveguide is absorbed at the end of the optical fiber.